Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyruvate Kinase Deficiency Global Longitudinal Registry: Patient-Reported Outcomes

NCT04964323 is registered in ClinicalTrials.gov with Agios Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04964323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04964323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyruvate Kinase Deficiency Global Longitudinal Registry: Patient-Reported Outcomes
Lead sponsor
Agios Pharmaceuticals, Inc.
Phase
Observational
Overall status
Terminated
Start date
July 2, 2021
Completion date
June 30, 2023
Enrollment
15 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, anemia, hemolytic, pyruvate kinase deficiency, pyruvate kinase deficiency anemia